NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Thu, 9 Jul · 19:40 IST

Neuland Labs files BRSR for FY 2025-26 with exchanges

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.0%1-day move
₹19563.00
prior close
₹19701.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.9-0.7-0.4-3.0-2.9-2.3-3.9-5.8-3.4
Up moveDown movePending
AI summary

Neuland Laboratories filed its Business Responsibility and Sustainability Report for FY 2025-26 with BSE and NSE on July 9, 2026, as required by SEBI LODR Regulation 34. Key figures: turnover about Rs 2,02,299 lakhs, exports at 76 percent of revenue, CSR spend of Rs 609 lakhs, 2,471 employees and 1,410 workers. BDO India provided reasonable assurance on BRSR Core indicators. Achievements include SBTi validation, launch of Neuland Foundation, transition to double materiality, and adoption of an AI Policy. No fines, penalties, or corruption cases reported.

Likely market impact

Routine compliance filing with ESG disclosures. SBTi validation, Neuland Foundation launch, and first independent BRSR assurance may appeal to ESG-focused long-term investors.